This site is intended for healthcare professionals

CPD
CPD
Pro
Pro
Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Beta-sitosterol plant extract in treatment of benign prostatic hyperplasia

Authoring team

Authors of a systematic review concluded (1):

  • evidence suggests non-glucosidic Beta-sitosterols improve urinary symptoms and flow measures. Their long term effectiveness, safety and ability to prevent benign prostatic hyperplasia (BPH) complications are not known

A Clinical Evidence review categorised beta-sitosterol plant extract as a treatment modality likely to be beneficial in BPH

Reference:

  1. Wilt T et al. Beta-sitosterols for benign prostatic hyperplasia. Cochrane Database Syst Rev. 2000;(2):CD001043
  2. Clinical Evidence (April 2006). Benign Prostatic Hyperplasia.

Related pages

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2025 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.